Gerrit Meijer

Full Professor

Strategic program(s):

Biography

Uitvraag registerFunctie (idem = nevenactiviteit soort)	Uitvraag registerNevenactiviteit organisatie - naam	Uitvraag registerNevenactiviteit start datum	Uitvraag registerNevenactiviteit inkomsten ja/nee

National Director	EATRIS-NL	2019	nee
vice voorzitter programmacommissie Personalzied medicine	ZonMW	2014	nee
National Node Director	BBMRI-NL	2014	nee
Member Publications Committee	AACR	2018	nee
Member Education and Training Committee	AACR	2020	nee
Member pathology task force	AACR	2018	nee
Member of the James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research Committee	AACR	2022	nee
External Advisory Committee	IPO Porto Research Center	2018	nee
Member of the Program Committee Translational Research	ZonMW	2018	nee
CSO	Health-RI	2020	nee
Member Scientific Advisory Board	German Medical Informatics Initiative	2019	nee
Member Supervisory Board	IKNL	2019	ja
Lid expertisegroep tijdelijke Commissie Regie op Registers voor Dure Geneesmiddelen	ZorgInstituut	2019	nee
AACR project GENIE steering committee	AACR	2016	nee
Lid raad van advies	Missie Primaire Tumor Onbekend	2021	nee
Member editorial board	Cellular Oncology	2012	nee
klankordgroep	Amgen	2021 eenmalig	nee
co-founder & shareholder	CRCbioscreen	2021	nee

Strategic program(s):

Contact

gmeijer7@umcutrecht.nl

Pure profile

Recent publications

All publications

Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer Axel Rosendahl Huber, Cayetano Pleguezuelos-Manzano, Jens Puschhof, Joske Ubels, Charelle Boot, Aurelia Saftien, Mark Verheul, Laurianne T. Trabut, Niels Groenen, Markus van Roosmalen, Kyanna S. Ouyang, Henry Wood, Phil Quirke, Gerrit Meijer, Edwin Cuppen, Hans Clevers, Ruben van Boxtel
Cancer Cell, 2024, vol. 42, p.487-496.e6

Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening setting Willemijn de Klaver, Meike de Wit, Anne Bolijn, Marianne Tijssen, Pien Delis-van Diemen, Margriet Lemmens, Manon C.W. Spaander, Evelien Dekker, Monique E. van Leerdam, Veerle M.H. Coupé, Ruben van Boxtel, Hans Clevers, Beatriz Carvalho, Gerrit A. Meijer
Journal of Pathology, 2024, vol. 263, p.217-225

Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice Kris G Samsom, Linda J W Bosch, Luuk J Schipper, Daoin Schout, Paul Roepman, Mirjam C Boelens, Ferry Lalezari, Elisabeth G Klompenhouwer, Adrianus J de Langen, Tineke E Buffart, Berit M H van Linder, Kelly van Deventer, Kay van den Burg, Unga Unmehopa, Efraim H Rosenberg, Roelof Koster, Frans B L Hogervorst, José G van den Berg, Immy Riethorst, Lieke Schoenmaker, Daphne van Beek, Ewart de Bruijn, Jacobus J M van der Hoeven, Hans van Snellenberg, Lizet E van der Kolk, Edwin Cuppen, Emile E Voest, Gerrit A Meijer, Kim Monkhorst
Nature protocols, 2023, vol. 19, p.700-726

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics Roelof Koster, Luuk J Schipper, Noor A A Giesbertz, Daphne van Beek, Matías Mendeville, Kris G Samsom, Efraim H Rosenberg, Frans B L Hogervorst, Paul Roepman, Mirjam C Boelens, Linda J W Bosch, Jose G van den Berg, Gerrit A Meijer, Emile E Voest, Edwin Cuppen, Marielle W G Ruijs, Tom van Wezel, Lizet van der Kolk, Kim Monkhorst
Genetics in medicine : official journal of the American College of Medical Genetics, 2023, vol. 26

Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice Kris G Samsom, Luuk J Schipper, Paul Roepman, Linda Jw Bosch, Ferry Lalezari, Elisabeth G Klompenhouwer, Adrianus J de Langen, Tineke E Buffart, Immy Riethorst, Lieke Schoenmaker, Daoin Schout, Vincent van der Noort, Jose G van den Berg, Ewart de Bruijn, Jacobus Jm van der Hoeven, Hans van Snellenberg, Lizet E van der Kolk, Edwin Cuppen, Emile E Voest, Gerrit A Meijer, Kim Monkhorst
Journal of Pathology, 2022, vol. 258, p.179-188

Cost-effectiveness of colorectal cancer surveillance in Hodgkin lymphoma survivors treated with procarbazine and/or infradiaphragmatic radiotherapy Berbel Lm Ykema, Andrea Gini, Lisanne S Rigter, Manon Cw Spaander, Leon Mg Moons, Tanya M Bisseling, Jan Paul de Boer, Wieke Hm Verbeek, Pieternella J Lugtenburg, Cecile Pm Janus, Eefke J Petersen, Judith M Roesink, Richard W M van der Maazen, Berthe Mp Aleman, Gerrit A Meijer, Flora E Van Leeuwen, Petur Snaebjornsson, Beatriz Carvalho, Monique E van Leerdam, Iris Lansdorp-Vogelaar
Cancer Epidemiology Biomarkers & Prevention, 2022, vol. 31, p.2157-2168